As Pandoraea infections in humans are rising Greek researchers provide more insights into such infections

Medical News: Pandoraea infections, once considered extremely rare, are becoming an emerging concern in the medical world. These infections, caused by a genus of Gram-negative bacteria, have been documented in increasing numbers, especially among individuals with compromised immune systems or severe chronic conditions. Greek researchers from leading institutions such as the University of Crete and Attikon University General Hospital of Athens have recently published a comprehensive review, shedding light on this rising threat. Their findings emphasize the critical need for awareness, early diagnosis, and tailored treatment protocols to combat these infections effectively.


As Pandoraea infections in humans are rising Greek researchers
provide more insights into such infections

This Medical News report explores the key findings of the Greek researchers and provides a detailed look at how Pandoraea infections are changing the landscape of infectious diseases.
 
What Is Pandoraea and Why Is It Dangerous?
First identified in 2000, Pandoraea is a genus of bacteria belonging to the Burkholderiaceae family. These bacteria are rod-shaped, aerobic, and known for their resilience and ability to survive in diverse environments, including the human body. While they are not inherently aggressive, Pandoraea species can exploit weaknesses in individuals with reduced immunity, such as those with cystic fibrosis (CF), cancer, or individuals who have undergone organ transplants.

Unlike many pathogens, Pandoraea poses a unique challenge due to its high resistance to commonly used antibiotics. Its ability to evade detection using standard laboratory tests also contributes to its underdiagnosis, leaving many infections untreated or improperly managed.
 
The Greek Study: A Comprehensive Overview
Greek researchers undertook a systematic review of 29 studies, analyzing 43 cases of Pandoraea infections globally. The study aimed to provide insights into the epidemiology, clinical manifestations, treatment options, and mortality rates associated with this emerging pathogen.
 
Who Is Most at Risk?
The analysis revealed that Pandoraea infections predominantly affect adults, with the mean age of patients being 42 years. Men were slightly more affected, comprising 58% of the documented cases. Risk factors included:
 
-Cystic Fibrosis (39.5% of cases): CF patients are particularly vulnerable as their compromised respiratory systems provide an ideal environment for bacterial growth.
 
-Recent Antibiotic Use (35%): Frequent or prolonged use of antibiotics can alter the natural microbial balance, paving the way for opportunistic infections like Pandoraea.
 
-Immunosuppression (18.6%): Conditions such as active cancer, organ transplantation, and autoimmune disorders often leave patients unable to fend off infections.
 
-Use of Central Venous Catheters (11.6%): These medical devices can serve as entry points for bacteria into the bloodstream.
 
Types of Pandoraea Infections
The Greek study identified a range of infections caused by Pandoraea species, with the respiratory system being the most frequently affected. Here are the key types:
 
-Respiratory Infections (74% of Cases):
Pandoraea infections in the lungs were common, particularly in CF patients. Symptoms ranged from chronic cough and difficulty breathing to severe respiratory failure. Polymicrobial infections, involving other pathogens like Pseudomonas aeruginosa, were frequently observed.
 
-Bloodstream Infections (30% of Cases):
Bacteremia, or the presence of bacteria in the blood, was a significant concern, often leading to sepsis and multi-organ failure. Patients with recent surgeries or central venous catheters were particularly at risk.
 
-Other Infections:
-Endocarditis: Infections of the heart valves were rare but severe, often requiring surgical intervention.
 
-Osteomyelitis: Pandoraea was found to infect bones, causing painful and debilitating symptoms.
 
-Pancreatic and Skin Infections: Though uncommon, these infections highlighted the bacterium's ability to invade diverse tissues.
 
Challenges in Diagnosis
Diagnosing Pandoraea infections is notoriously difficult. Standard microbiological techniques often misidentify Pandoraea as other bacteria, such as Burkholderia or Ralstonia. Advanced genetic methods like 16S rRNA sequencing and MALDI-TOF mass spectrometry are required for accurate identification. However, these tools are expensive and not widely available, particularly in low-resource settings.
 
The review highlighted that many cases of Pandoraea were likely undiagnosed or misdiagnosed, contributing to poor outcomes. It emphasized the importance of heightened clinical suspicion, especially in high-risk patients.
 
The Antibiotic Resistance Puzzle
Pandoraea species exhibit alarming levels of resistance to multiple antibiotics, including:
 
-Beta-lactams: Nearly all species are resistant to this commonly used class of antibiotics.
 
-Aminoglycosides and Quinolones: High resistance rates were observed.
Carbapenems: While generally effective, resistance to certain carbapenems like meropenem was documented.
 
Interestingly, imipenem, a type of carbapenem, showed the most promise in treating these infections. However, treatment success often depended on the timely initiation of appropriate antibiotics, guided by laboratory susceptibility testing.
 
Treatment Strategies: A Long Way to Go
There are currently no standardized treatment guidelines for Pandoraea infections. Most cases rely on empirical treatment while waiting for lab results.
 
Key strategies include:
-Antibiotic Therapy: Carbapenems, cephalosporins, and trimethoprim-sulfamethoxazole are commonly used, but their effectiveness varies.
 
-Surgical Interventions: In severe cases, surgical removal of infected devices or tissues may be necessary.
 
-Supportive Care: Managing complications like respiratory failure or sepsis is critical.
 
The study also emphasized the importance of tailored treatment plans based on individual patient needs and infection severity.
 
Mortality Rates and Outcomes
The findings of the Greek study revealed sobering statistics:
 
-Overall mortality rate: 30%
 
-Mortality from bloodstream infections: Significantly higher
 
-Mortality in CF patients: Elevated due to chronic lung damage and frequent hospitalizations.
 
These figures underscore the seriousness of Pandoraea infections and the urgent need for improved diagnostic and treatment approaches.
 
The Future of Pandoraea Research
Despite the wealth of information provided by the Greek researchers, many questions remain unanswered. For instance:
 
-What specific mechanisms make Pandoraea so resistant to antibiotics?
 
-How does the bacterium evade the immune system in immunocompromised patients?
 
-Can early interventions, such as preventive antibiotics or advanced screening methods, reduce mortality rates?
 
Addressing these gaps will require global collaboration and investment in research. Developing rapid diagnostic tools and new antibiotics tailored to combat Pandoraea is also critical.
 
Conclusion: A Call to Action
Pandoraea infections are a rising threat, particularly to vulnerable populations. While still relatively rare, their high mortality rates and resistance to antibiotics make them a formidable challenge for healthcare systems worldwide. The work of Greek researchers has provided invaluable insights, but it also highlights the pressing need for further studies and international cooperation.
 
Healthcare providers must remain vigilant, ensuring early diagnosis and aggressive treatment. Patients with risk factors, such as cystic fibrosis or recent surgeries, should be closely monitored for signs of infection.
 
In the fight against Pandoraea and other emerging pathogens, knowledge is our most powerful weapon.
 
The study findings were published in the peer reviewed Journal of Clinical Medicine.
https://www.mdpi.com/2077-0383/13/22/6905
 
For the latest news, keep on logging to Thailand Medical News.
 
Read Also:
https://www.thailandmedical.news/news/medical-news-lassa-fever-outbreak-in-oyo-nigeria-kills-hospital-owner-and-three-hospital-staff
 
https://www.thailandmedical.news/news/uk-reports-66730-antibiotic-resistant-infections-in-2023-2024-set-to-break-even-more-alarming-records